The long-term effects of respiratory viral infections such as COVID-19 are a major public health burden. Some estimates suggest over 65 million people around the world suffer from long COVID-19.

LUBBOCK, Texas. - A Texas doctor is noticing a pattern in her patients that could reveal another possible devastating side effect of COVID-19: severely scarred lungs. Dr. Brittany Bankhead-Kendall, a ...

When breathing becomes increasingly difficult with no clear explanation, idiopathic pulmonary fibrosis (IPF) might be the culprit behind the concerning symptoms. This rare yet devastating lung disease ...

Arthritis drugs already available for prescription have the potential to halt lingering lung problems that can last months or years after COVID-19 infections, new research from the University of ...

The most common type of lung fibrosis - scarring of the lungs -- is idiopathic, meaning of unknown cause. Researchers are urgently trying to find ways to prevent or slow idiopathic pulmonary fibrosis ...

Researchers at Tulane University have identified a potential new way to treat idiopathic pulmonary fibrosis (IPF), a deadly and currently incurable lung disease that affects more than 3 million people ...

What Is Jascayd, and Why Does It Matter? Jascayd (nerandomilast) is a new oral medicine approved to treat idiopathic pulmonary fibrosis (IPF) in adults. IPF is a rare and serious condition that causes ...

Pulmonary sarcoidosis is a condition that causes tiny groups of immune cells to clump in your lungs. These groups of cells form swollen, inflamed lumps called granulomas. Granulomas can make it hard ...

Systemic sclerosis is, as the name defines, a thickening of the tissues in the skin. And it's also involving multiple organs in the body, not just the skin. And one of these is the lungs, so there's a ...

Lung disease is a general term for several disorders that include airway diseases, lung tissue diseases, and lung circulation diseases, some of which may lead to respiratory failure. During the course ...